755
Participants
Start Date
January 31, 2006
Primary Completion Date
September 30, 2008
Study Completion Date
July 31, 2013
folate
Intravenous repeating dose
methotrexate
Oral or parenteral repeating dose
methylprednisolone
Intravenous repeating dose
placebo
Intravenous repeating dose
rituximab
Intravenous repeating dose
Lead Sponsor
Hoffmann-La Roche
INDUSTRY
Genentech, Inc.
INDUSTRY